However, Sphk2-KO significantly ameliorated immune cell infiltration, hepatocyte ballooning, NAFLD activity score (NAS) and hepatic fibrosis in non-tumorous tissues (Fig. 2C–F), which are classic hallmarks of pro-carcinogenic injury in NAFLD-HCC. This evidence concerns the gene SPHK2 and hepatocellular carcinoma.